Healthcare and Life Sciences

Contact Us

Duff & Phelps Healthcare and Life Sciences team provides Fortune 500 corporations, middle-market and growth companies and financial sponsors access to our valuation and corporate finance services.

Our dedicated team completes nearly 200 healthcare engagements annually, including engagements in healthcare services, Pharmaceuticals, Medical Technology and Life Sciences. As a firm, Duff & Phelps stands alone in our objectivity, deep technical and industry expertise and breadth of advisory services.

/industries/healthcare-and-life-sciences /-/media/feature/industries/desktop/health-life-sciences.jpg industry {13E28841-C245-441D-8C3B-49E72DA5381C} {BAF3E1CE-54B1-4448-B2FD-00B1585CD18A} {9B44E83A-E993-4902-AAE0-82849CEAD728} {E010DCD9-B7BA-4B98-9F3C-A51506B5C1D8} {4DACD310-421A-42AC-BEF4-8AA7E70484CD}

Other Areas We Can Help

Purchase Price Allocation (PPA)

Financial Sponsor Group

Dedicated coverage and access to M&A deal-flow for financial sponsors.

Financial Sponsor Group

Valuation Services

Valuation and asset appraisal for financial reporting, income tax, investment and risk management purposes.

Valuation Services

M&A Advisory

Middle-market M&A advisory differentiated by industry expertise and superior execution.

M&A Advisory

Case Studies

Insights

LIBOR Update

Duff & Phelps LIBOR Transition Advisory Newsletter – November 2021

LIBOR Update
M&A Advisory

Healthcare Services Sector Update – Early Winter 2021

M&A Advisory
M&A Advisory

Global Software Sector Update – Fall 2021

M&A Advisory
Valuation

Hong Kong Listings Offer Ring-Fenced Route to China

Valuation

News

Featured Events

State Taxation of Digital Goods, Services and Software

Calendar

Location